Stock Price
140.31
Daily Change
1.38 0.99%
Monthly
-1.34%
Yearly
-42.92%
Q2 Forecast
135.92

CSL reported $3.17B in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 55.07M 51.01M Dec/2025
Bio Path USD 4.9M 1.42M Sep/2025
Brainstorm Cell Therapeutics USD 7.07M 647K Dec/2025
Cara Therapeutics USD 4.08M 1.65M Sep/2025
CSL USD 3.17B 290M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Immunic USD 7.92M 25K Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024